Boston, MA -- (SBWIRE) -- 12/20/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN), Axa SA (ADR) (OTCMKTS:AXAHY), LSI Corp(NASDAQ:LSI), Horizon Pharma Inc (NASDAQ:HZNP).
Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN), opened its shares at the price of $0.44 for the day. Its closing price was $0.522 after gaining18.84% for the day. The company traded with the total volume of 2.68 million shares, while its average trading volume remained 941,488 shares. The beta of IVAN stands at2.48
Ivanhoe Energy Inc., together with its subsidiaries, engages in the development and production of oil and gas properties.
Will IVAN Continue To Move Higher? Find Out Here
Axa SA (ADR) (OTCMKTS:AXAHY), percentage change surged2.15 % to close at $26.63 with the total traded volume of 922,078 shares, and average volume of 108,904. The 52 week range of the stock remained $16.60 - $26.70, while its day lowest price was $26.30 and it hit its day highest price at $26.70.
AXA Group, through its subsidiaries, provides insurance and asset management services
Will AXAHY Continue To Move Higher? Find Out Here
LSI Corp(NASDAQ:LSI), started its trading session with the price of $10.94 and closed at $10.93 by scoring 0.09%. LSI’s stocks traded with total volume of 26.20 million shares, while the average trading volume remained 13.36 million shares. The beta of LSI stands at 1.49. Day range of the stock was $10.92 -$10.95.
LSI Corporation designs, develops, and markets storage and networking semiconductors worldwide.
Will LSI Continue To Move Higher? Find Out Here
Horizon Pharma Inc (NASDAQ:HZNP) ended its day with the gain of 4.42% and closed at the price of $7.08 after opening at $6.84. Stock traded during its last trading session with the total volume of 5.52 million shares, as compared to its average volume of 1.80 million shares.
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases.
Will HZNP Continue To Move Higher? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)